Ally Bridge Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-160,000
Closed -$3.04M 44
2022
Q2
$3.04M Buy
+160,000
New +$3.04M 2.77% 17